Steven Payne is CAO at GLOBUS MEDICAL INC (GMED). They have made 5 open-market trades across 1 company since 2012, most recently 2018-09-26.
CIK 0001578733
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GMED | 3,000 | $261K |
Shares reported on the most recent Form 4, priced at the 2018-10-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GMED | SELL | 2018-09-26 | 2018-10-30 | $56.00 | $168K | -2.2% | -9.7% | -17.5% |
| GMED | SELL | 2018-05-31 | 2018-06-04 | $55.81 | $2.3M | -0.1% | -8.7% | -5.4% |
| GMED | SELL | 2017-12-15 | 2017-12-18 | $39.30 | $242K | +4.8% | +10.3% | +29.3% |
| GMED | SELL | 2015-05-28 | 2015-06-01 | $25.92 | $80K | -7.9% | -2.9% | -2.9% |
| GMED | SELL | 2012-08-08 | 2013-06-11 | $11.16 | $26K | -7.9% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.